GLAXO Financial Statements

Glaxosmithkline Pharmaceuticals Key Financial Ratios

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2017 Mar-2016
Growth matrix (%)        
Revenue growth (0.80) 10.90 2.49 (14)
Op profit growth 5.79 56.90 (12) (24)
EBIT growth 11.20 40.30 (19) (29)
Net profit growth 284 (72) (10) (21)
Profitability ratios (%)        
OPM 21.70 20.40 14.40 16.90
EBIT margin 22.70 20.30 16 20.30
Net profit margin 11.20 2.89 11.60 13.30
RoCE 43.30 33.90 22.10 28.60
RoNW 5.39 1.22 4.02 4.69
RoA 5.34 1.21 3.99 4.66
Per share ratios ()        
EPS 21.10 5.50 39.80 31.70
Dividend per share 30 40 30 50
Cash EPS 16.50 0.62 36.70 41.50
Book value per share 88.50 107 237 258
Valuation ratios        
P/E 68.10 226 34.40 60
P/CEPS 87.50 2,004 37.30 45.80
P/B 16.30 11.60 5.77 7.37
EV/EBIDTA 28.80 27.20 45.30 51.20
Payout (%)        
Dividend payout -- -- 75.40 169
Tax payout (27) (33) (37) (35)
Liquidity ratios        
Debtor days 18 15.30 18.70 14.60
Inventory days 58.70 51.40 59.70 58
Creditor days (62) (64) (68) (57)
Leverage ratios        
Interest coverage (206) (103) (1,863) (2,438)
Net debt / equity (0.80) (0.60) (0.40) (0.60)
Net debt / op. profit (1.70) (1.60) (2.10) (2.90)
Cost breakup ()        
Material costs (41) (41) (48) (43)
Employee costs (19) (19) (17) (16)
Other costs (18) (20) (21) (24)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2017 Mar-2016
Revenue 3,199 3,224 2,908 2,838
yoy growth (%) (0.80) 10.90 2.49 (14)
Raw materials (1,313) (1,308) (1,398) (1,233)
As % of sales 41 40.60 48.10 43.50
Employee costs (615) (629) (483) (443)
As % of sales 19.20 19.50 16.60 15.60
Other costs (576) (631) (609) (683)
As % of sales 18 19.60 20.90 24.10
Operating profit 695 657 419 478
OPM 21.70 20.40 14.40 16.90
Depreciation (79) (83) (26) (25)
Interest expense (3.50) (6.30) (0.30) (0.20)
Other income 111 79 73.10 123
Profit before tax 723 647 465 576
Taxes (192) (213) (174) (202)
Tax rate (27) (33) (37) (35)
Minorities and other -- -- -- --
Adj. profit 531 435 291 374
Exceptional items (173) (341) 45.70 2.31
Net profit 358 93.20 337 376
yoy growth (%) 284 (72) (10) (21)
NPM 11.20 2.89 11.60 13.30
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2017 Mar-2016
Profit before tax 723 647 465 576
Depreciation (79) (83) (26) (25)
Tax paid (192) (213) (174) (202)
Working capital (818) (1,013) (771) 114
Other operating items -- -- -- --
Operating cashflow (367) (661) (506) 463
Capital expenditure 285 1,138 (38) (135)
Free cash flow (82) 478 (544) 328
Equity raised 2,907 3,565 3,744 3,996
Investments (112) (55) (10) 5.98
Debt financing/disposal 4.93 4.77 5.74 5.49
Dividends paid -- -- 254 529
Other items -- -- -- --
Net in cash 2,718 3,992 3,450 4,865
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 169 169 169 84.70
Preference capital -- -- -- --
Reserves 1,330 1,651 1,970 1,973
Net worth 1,499 1,821 2,140 2,057
Minority interest
Debt 0.02 0.18 0.58 0.99
Deferred tax liabilities (net) 15.60 17.20 24.10 16.20
Total liabilities 1,515 1,838 2,165 2,075
Fixed assets 399 878 1,434 1,247
Intangible assets
Investments -- -- 0.06 0.06
Deferred tax asset (net) 119 128 86.30 120
Net working capital (161) (251) (527) (589)
Inventories 547 483 486 500
Inventory Days 62.40 54.70 -- --
Sundry debtors 216 99.80 120 147
Debtor days 24.60 11.30 -- --
Other current assets 691 479 636 653
Sundry creditors (467) (381) (483) (646)
Creditor days 53.20 43.10 -- --
Other current liabilities (1,148) (931) (1,288) (1,243)
Cash 1,158 1,083 1,171 1,296
Total assets 1,515 1,838 2,165 2,075
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021
Gross Sales 810 816 934 790 744
Excise Duty -- -- -- -- --
Net Sales 810 816 934 790 744
Other Operating Income -- -- -- -- --
Other Income 1,322 22.40 28.40 31.70 40.30
Total Income 2,132 838 962 822 785
Total Expenditure ** 634 636 676 638 707
PBIDT 1,497 202 286 183 78
Interest 0.28 0.58 0.35 0.79 0.63
PBDT 1,497 202 286 183 77.30
Depreciation 15.40 17.90 17.40 17.70 17.70
Minority Interest Before NP -- -- -- -- --
Tax 260 38.90 67.70 47 34
Deferred Tax 2.55 (5.50) (3.30) (3.20) 11.30
Reported Profit After Tax 1,219 150 204 121 14.30
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 1,219 150 204 121 14.30
Extra-ordinary Items (7.80) (14) -- -- (8.90)
Adjusted Profit After Extra-ordinary item 1,227 164 204 121 23.20
EPS (Unit Curr.) 72 8.87 12.90 7.15 0.85
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 169 169 169 169 169
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 185 24.80 30.70 23.20 10.50
PBDTM(%) 185 24.70 30.60 23.10 10.40
PATM(%) 151 18.40 21.90 15.30 1.92
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity